Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10763| Title: | Established, emerging and future roles of PET/CT in the management of colorectal cancer. | Austin Authors: | Herbertson, R A;Scarsbrook, A F;Lee, S T;Tebbutt, Niall C ;Scott, Andrew M | Affiliation: | rebecca.herbertson@ludwig.edu.au Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Victoria, Australia |
Issue Date: | 23-Oct-2008 | Publication information: | Clinical Radiology 2008; 64(3): 225-37 | Abstract: | Positron-emission tomography-computed tomography (PET/CT) is rapidly being integrated into the imaging pathways of several different tumour types, most frequently using the glucose analogue 2- [(18)F]-fluoro-2-deoxy-D-glucose (FDG). Integrated FDG-PET/CT combines functional and anatomical imaging to improve sensitivity and specificity of tumour detection. The aim of this article is to review the established, emerging, and future roles of FDG-PET/CT in the management of patients with colorectal cancer (CRC). | Gov't Doc #: | 19185652 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/10763 | DOI: | 10.1016/j.crad.2008.08.008 | Journal: | Clinical radiology | URL: | https://pubmed.ncbi.nlm.nih.gov/19185652 | Type: | Journal Article | Subjects: | Colonoscopy Colorectal Neoplasms.drug therapy.radionuclide imaging Cost-Benefit Analysis Fluorodeoxyglucose F18.diagnostic use Great Britain Humans Neoplasm Recurrence, Local.radionuclide imaging Neoplasm Staging Neoplasm, Residual Positron-Emission Tomography.economics.methods.trends Radiopharmaceuticals.diagnostic use Radiotherapy Planning, Computer-Assisted Sensitivity and Specificity Tomography, X-Ray Computed.economics.methods.trends |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.